BioPlus Acquisition Corp. BIOS
10.80 +10.80
Day range unavailable
52-week range unavailable
News
gurufocus.com COMPUTEX 2026: MiTAC Advances Diversified AI Infrastructure Through Strategic Ecosystem Partnerships COMPUTEX 2026: MiTAC Advances Diversified AI Infrastructure Through Strategic Ecosystem Partnerships PR Newswire
globenewswire.com BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate New York, NY, Oct. 04, 2023 (GLOBE NEWSWIRE) -- BioPlus Acquisition Corp. (“BIOS” or the “Company”) (Nasdaq: BIOS) announced today that (i) BIOS, Avertix Medical, Inc. and certain other parties have…
globenewswire.com Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation - Transaction values Avertix at an enterprise value of $195 million - Avertix developed the Guardian™ System, the first and only FDA-approved solution designed to detect and warn patients of cardiac…
globenewswire.com BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering NEW YORK, Dec. 06, 2021 (GLOBE NEWSWIRE) -- BioPlus Acquisition Corp. (the “Company”) announced today that it priced its upsized initial public offering of 20,000,000 units at $10.00 per unit. The…
globenewswire.com Option Care Health Completes Reverse Stock Split and Ticker Symbol Change BANNOCKBURN, Ill., Feb. 03, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate…
benzinga.com Stocks That Hit 52-Week Highs On Tuesday 
benzinga.com Stocks That Hit 52-Week Highs On Friday 
benzinga.com Stocks That Hit 52-Week Highs On Thursday 
benzinga.com Stocks That Hit 52-Week Highs On Thursday 
globenewswire.com Option Care Health Selected by Highmark as Preferred Provider of Hemophilia Treatment National leader in treating bleeding disorders offers personalized, high-quality patient care National leader in treating bleeding disorders offers personalized, high-quality patient care
businesswire.com Option Care Health to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference BANNOCKBURN, Ill.--(BUSINESS WIRE)--Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent national provider of home and alternate site infusion services, today announced that John…
businesswire.com Option Care Health Receives Anticipated Nasdaq Notice BANNOCKBURN, Ill.--(BUSINESS WIRE)--Option Care Health, Inc. (Nasdaq: BIOS) announced today that on August 7, 2019, it received a letter from the Nasdaq Staff informing it that, since the merger…
businesswire.com Option Care and BioScrip Complete Merger to Form Option Care Health BANNOCKBURN, Ill. & DENVER--(BUSINESS WIRE)--Option Care Enterprises, Inc. (“Option Care”) and BioScrip, Inc. (“BioScrip”) today announced the successful completion of their merger, which follows the…
benzinga.com 75 Biggest Movers From Friday - benzinga.com 51 Stocks Moving In Friday's Mid-Day Session
- benzinga.com Stocks Which Set New 52-Week High Yesterday, Thurs., Dec. 13, 2018
- benzinga.com Stocks Which Set New 52-Week High Yesterday, Thurs., Nov. 29, 2018
benzinga.com Stocks Which Set New 52-Week High Yesterday, Wed., Nov. 28, 2018 - benzinga.com Stocks Which Set New 52-Week High Yesterday, Tues., Nov. 27, 2018
- benzinga.com Stocks Which Set New 52-Week High Yesterday, Mon., Nov. 26, 2018
benzinga.com 41 Biggest Movers From Yesterday - benzinga.com Stocks Which Set New 52-Week High The Prior Trading Session, Fri., Nov. 23, 2018
benzinga.com Stocks Which Set New 52-Week High Yesterday, Wed., Nov. 7, 2018 - benzinga.com 60 Stocks Moving In Tuesday's Mid-Day Session
businesswire.com BioScrip Provides Update on Annual Form 10-K Filing Status DENVER--(BUSINESS WIRE)--BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that it…
businesswire.com INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an
Investigation Involving Possible Securities Fraud Violations by the
Board of Directors of BioScrip, Inc. -- BIOS NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky announces it has commenced an investigation of BioScrip, Inc. (NASDAQGM: BIOS) concerning possible violations of federal securities laws. On March 8, 2018,…
businesswire.com Glancy Prongay & Murray LLP Announces Investigation on Behalf of
BioScrip, Inc. Investors LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of BioScrip, Inc. (“BioScrip” or the “Company”) (NASDAQ: BIOS) investors concerning the Company…
businesswire.com SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an
Investigation Involving Possible Securities Fraud Violations by the
Board of Directors of BioScrip, Inc. NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky announces it has commenced an investigation of BioScrip, Inc. (NASDAQGM:BIOS) concerning possible violations of federal securities laws. On March 8, 2018,…
businesswire.com BioScrip Reports Fourth Quarter and Full Year 2017 Financial Results DENVER--(BUSINESS WIRE)--BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its…
businesswire.com BioScrip Reports Fourth Quarter and Full Year 2017 Financial Results DENVER--(BUSINESS WIRE)--BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its…
businesswire.com BioScrip Schedules Release of Fourth Quarter and Full Year 2017
Financial Results and Conference Call DENVER--(BUSINESS WIRE)--BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that…
businesswire.com BioScrip Announces U.S. Congress Passage of Medicare Home Infusion
Transition Benefit, Effective 2019 DENVER--(BUSINESS WIRE)--BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the…
businesswire.com BioScrip, Inc. Joins Coalition to Advocate for
Vulnerable Medicare Patients Losing Access to Home Infusion Care DENVER--(BUSINESS WIRE)--BioScrip, Inc. (NASDAQ:BIOS), a leading national provider of infusion and home care management solutions, announced today it has joined a newly established coalition, Keep My…
businesswire.com BioScrip Reports Third Quarter 2015 Financial Results ELMSFORD, N.Y.--(BUSINESS WIRE)--BioScrip, Inc. (NASDAQ:BIOS) (“the Company”) today announced 2015 third quarter financial results. Third Quarter Highlights Consolidated Adjusted EBITDA was $6.2…- businesswire.com BioScrip Reports Third Quarter 2015 Financial Results ELMSFORD, N.Y.--(BUSINESS WIRE)--BioScrip, Inc. (NASDAQ:BIOS) (“the Company”) today announced 2015 third quarter financial results. Third Quarter Highlights Consolidated Adjusted EBITDA was $6.2…
- benzinga.com Thursday's After-Hours Movers: NeoPhotonics, Quality Distribution And More